kenvue.com (KVUE): Net earnings per share growth forecast for next year
Kenvue Inc. (KVUE) is actively engaging third-party operators for the logistics and promotion of its hygiene brands. The expected EPS growth for the coming year reflects market expectations, with 7.10 representing the current level of the metric. The company is diversifying supply risks through contract packaging while maintaining its proprietary formulas. High capacity utilization and the systematic automation of plants further bolster the business's stability.
Analytical breakdowns for Kenvue Corp (KVUE)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- net income and valuation ratios data:
KVUE - Final Profit|Projected Future Earnings Kenvue Inc.|KVUE - Business Payback Period|Future Price to Earnings Kenvue Corp|KVUE - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Kenvue Corp|KVUE - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Kenvue|KVUE - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months kenvue.com|KVUE - Earnings growth in current year|Expected earnings per share growth for next year Kenvue Inc.
- revenue and sales proceeds data:
Summary company analysis:Kenvue Health
Assessing the asset quality of Kenvue Inc. (KVUE) requires analyzing future profitability through the lens of market expectations. The consensus earnings per share (EPS) forecast vector reflects analysts' weighted average assessment of EPS growth rates, measuring the business's ability to scale net income. For Kenvue Inc. (KVUE), this indicator confirms the effectiveness of its pricing power over the Tylenol and Listerine brands. The stable trend of this metric signals a reliable influx of institutional capital.
Main competitors
Net earnings per share growth forecast for next year Haleon plc|Expected net earnings per share growth next year veronapharma.com VRNA|Net earnings per share growth forecast for next year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Expected earnings per share trend next year|Earnings growth forecast for next year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Net earnings per share change forecast for next year|ALVO - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year liquidia.com LQDA|Galapagos (GLPG) - Net earnings per share growth forecast for next year|ANIP - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year MannKind Corporation|AMPH: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Pacira BioSciences (PCRX)|SPRY: Net earnings per share change forecast for next year|Theravance Biopharma, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year AQST (Aquestive Therapeutics, Inc.)|SCPH - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year tectonictx.com TECX|TNXP: Earnings growth forecast for next year|Projected earnings per share growth rate for next year SXTC|Expected earnings per share growth for next year EPRX|BioHarvest (BHST) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year EXOZ|Earnings growth forecast for next year Oramed (ORMP)|Entera Bio Ltd. - Expected earnings per share growth for next year|ipatherapeutics.com (HYFT) - Expected net earnings per share growth next year|ABVC - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year CPIX|QNTM: Earnings growth forecast for next year|FGEN - Consensus forecast of earnings per share growth for next year|TELO (Telomir Pharmaceuticals Corp) - Earnings growth forecast for next year|RANI (Rani Therapeutics) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Synergy CHC Corp. (SNYR)|RLYB (Rallybio) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year lexariabioscience.com LEXX|Earnings growth forecast for next year Pulmatrix Corporation PULM|PTHL - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Expected earnings per share growth for next year|IBO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year TNF Pharmaceuticals, Inc.|Expected earnings per share growth for next year cbdMD, Inc. (YCBD)|Net earnings per share growth forecast for next year PainReform Limited (PRFX)|Expected earnings per share growth for next year Altamira Therapeutics Ltd CYTO|Earnings growth forecast for next year LIPO (lipella.com)|Expected earnings per share trend next year OPTN|PIRS - Net earnings per share growth forecast for next year|Procaps Group Corp (PROC) - Expected earnings per share growth for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year QLI (Qilian International)|Expected earnings per share growth for next year SLRN|TFF Pharmaceuticals, Inc. - Net earnings per share change forecast for next year
